633 related articles for article (PubMed ID: 22019123)
1. The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles.
Zhang Y; Zhang H; Wang X; Wang J; Zhang X; Zhang Q
Biomaterials; 2012 Jan; 33(2):679-91. PubMed ID: 22019123
[TBL] [Abstract][Full Text] [Related]
2. A potential target associated with both cancer and cancer stem cells: a combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes.
Liu Y; Lu WL; Guo J; Du J; Li T; Wu JW; Wang GL; Wang JC; Zhang X; Zhang Q
J Control Release; 2008 Jul; 129(1):18-25. PubMed ID: 18466993
[TBL] [Abstract][Full Text] [Related]
3. Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells.
Ke XY; Lin Ng VW; Gao SJ; Tong YW; Hedrick JL; Yang YY
Biomaterials; 2014 Jan; 35(3):1096-108. PubMed ID: 24183698
[TBL] [Abstract][Full Text] [Related]
4. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
[TBL] [Abstract][Full Text] [Related]
5. The efficiency of tumor-specific pH-responsive peptide-modified polymeric micelles containing paclitaxel.
Zhao BX; Zhao Y; Huang Y; Luo LM; Song P; Wang X; Chen S; Yu KF; Zhang X; Zhang Q
Biomaterials; 2012 Mar; 33(8):2508-20. PubMed ID: 22197569
[TBL] [Abstract][Full Text] [Related]
6. Role of cellular uptake in the reversal of multidrug resistance by PEG-b-PLA polymeric micelles.
Xiao L; Xiong X; Sun X; Zhu Y; Yang H; Chen H; Gan L; Xu H; Yang X
Biomaterials; 2011 Aug; 32(22):5148-57. PubMed ID: 21546083
[TBL] [Abstract][Full Text] [Related]
7. The antiangiogenic efficacy of NGR-modified PEG-DSPE micelles containing paclitaxel (NGR-M-PTX) for the treatment of glioma in rats.
Zhao BJ; Ke XY; Huang Y; Chen XM; Zhao X; Zhao BX; Lu WL; Lou JN; Zhang X; Zhang Q
J Drug Target; 2011 Jun; 19(5):382-90. PubMed ID: 20677914
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin receptor-mediated tumor-targeting drug delivery using octreotide-PEG-deoxycholic acid conjugate-modified N-deoxycholic acid-O, N-hydroxyethylation chitosan micelles.
Huo M; Zou A; Yao C; Zhang Y; Zhou J; Wang J; Zhu Q; Li J; Zhang Q
Biomaterials; 2012 Sep; 33(27):6393-407. PubMed ID: 22704599
[TBL] [Abstract][Full Text] [Related]
9. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery.
Soga O; van Nostrum CF; Fens M; Rijcken CJ; Schiffelers RM; Storm G; Hennink WE
J Control Release; 2005 Mar; 103(2):341-53. PubMed ID: 15763618
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin receptor-mediated specific delivery of paclitaxel prodrugs for efficient cancer therapy.
Huo M; Zhu Q; Wu Q; Yin T; Wang L; Yin L; Zhou J
J Pharm Sci; 2015 Jun; 104(6):2018-2028. PubMed ID: 25820241
[TBL] [Abstract][Full Text] [Related]
11. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
12. Improving anti-tumor activity with polymeric micelles entrapping paclitaxel in pulmonary carcinoma.
Gong C; Xie Y; Wu Q; Wang Y; Deng S; Xiong D; Liu L; Xiang M; Qian Z; Wei Y
Nanoscale; 2012 Sep; 4(19):6004-17. PubMed ID: 22910790
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel-loaded polymeric micelles based on poly(ɛ-caprolactone)-poly(ethylene glycol)-poly(ɛ-caprolactone) triblock copolymers: in vitro and in vivo evaluation.
Zhang L; He Y; Ma G; Song C; Sun H
Nanomedicine; 2012 Aug; 8(6):925-34. PubMed ID: 22101107
[TBL] [Abstract][Full Text] [Related]
14. Transferrin-conjugated micelles: enhanced accumulation and antitumor effect for transferrin-receptor-overexpressing cancer models.
Yue J; Liu S; Wang R; Hu X; Xie Z; Huang Y; Jing X
Mol Pharm; 2012 Jul; 9(7):1919-31. PubMed ID: 22616905
[TBL] [Abstract][Full Text] [Related]
15. Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery.
Liu Y; Sun J; Cao W; Yang J; Lian H; Li X; Sun Y; Wang Y; Wang S; He Z
Int J Pharm; 2011 Dec; 421(1):160-9. PubMed ID: 21945183
[TBL] [Abstract][Full Text] [Related]
16. Galactose-decorated cross-linked biodegradable poly(ethylene glycol)-b-poly(ε-caprolactone) block copolymer micelles for enhanced hepatoma-targeting delivery of paclitaxel.
Yang R; Meng F; Ma S; Huang F; Liu H; Zhong Z
Biomacromolecules; 2011 Aug; 12(8):3047-55. PubMed ID: 21726090
[TBL] [Abstract][Full Text] [Related]
17. Biodegradable polymeric micelles coencapsulating paclitaxel and honokiol: a strategy for breast cancer therapy in vitro and in vivo.
Wang N; Wang Z; Nie S; Song L; He T; Yang S; Yang X; Yi C; Wu Q; Gong C
Int J Nanomedicine; 2017; 12():1499-1514. PubMed ID: 28260895
[TBL] [Abstract][Full Text] [Related]
18. Vitamin E-based redox-sensitive salinomycin prodrug-nanosystem with paclitaxel loaded for cancer targeted and combined chemotherapy.
Liang DS; Liu J; Peng TX; Peng H; Guo F; Zhong HJ
Colloids Surf B Biointerfaces; 2018 Dec; 172():506-516. PubMed ID: 30212688
[TBL] [Abstract][Full Text] [Related]
19. CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel.
Muntimadugu E; Kumar R; Saladi S; Rafeeqi TA; Khan W
Colloids Surf B Biointerfaces; 2016 Jul; 143():532-546. PubMed ID: 27045981
[TBL] [Abstract][Full Text] [Related]
20. ShRNA targeting Notch1 sensitizes breast cancer stem cell to paclitaxel.
Mao J; Song B; Shi Y; Wang B; Fan S; Yu X; Tang J; Li L
Int J Biochem Cell Biol; 2013 Jun; 45(6):1064-73. PubMed ID: 23500524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
